Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Rallybio Corporation, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Entrada Therapeutics Inc. June 11, 202588.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 16, 2026 | Skye Bioscience Inc. | Open-market sale | −32,607 | $1.91 | $62,279 |
| Sep 16, 2026 | Skye Bioscience Inc. | Open-market sale | −1,285 | $1.91 | $2,454 |
| Aug 10, 2026 | Entrada Therapeutics Inc. | Open-market sale | −92,444 | $7.00 | $647,108 |
| Aug 7, 2026 | Entrada Therapeutics Inc. | Open-market sale | −52,317 | $6.85 | $358,371 |
| Aug 6, 2026 | Entrada Therapeutics Inc. | Open-market sale | −10,494 | $7.00 | $73,458 |
| Jul 31, 2026 | Entrada Therapeutics Inc. | Open-market sale | −1,718 | $6.85 | $11,768 |
| Jul 30, 2026 | Entrada Therapeutics Inc. | Open-market sale | −114,756 | $6.93 | $795,259 |
| Nov 14, 2025 | Entrada Therapeutics Inc. | Open-market sale | −200,000 | $8.80 | $1,760,000 |
| Jul 9, 2025 | Entrada Therapeutics Inc. | Open-market sale | −20,065 | $7.50 | $150,488 |
| Jul 9, 2025 | Entrada Therapeutics Inc. | Open-market sale | −6,935 | $7.50 | $52,013 |
| Jul 1, 2025 | Entrada Therapeutics Inc. | Open-market sale | −18,578 | $7.12 | $132,275 |
| Jul 1, 2025 | Entrada Therapeutics Inc. | Open-market sale | −6,422 | $7.12 | $45,725 |
| Jun 30, 2025 | Entrada Therapeutics Inc. | Open-market sale | −18,578 | $6.81 | $126,516 |
| Jun 30, 2025 | Entrada Therapeutics Inc. | Open-market sale | −6,422 | $6.81 | $43,734 |
| Jun 27, 2025 | Entrada Therapeutics Inc. | Open-market sale | −55,735 | $6.91 | $385,129 |
Questions about Kush Parmar
What boards is Kush Parmar on?
Kush Parmar sits on the boards of Entrada Therapeutics Inc. and Rallybio Corporation.
How long has Kush Parmar served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.